BMO Capital Maintains Outperform on AMN Healthcare Services, Raises Price Target to $40
BMO Capital analyst Jeffrey Silber maintains AMN Healthcare Services (NYSE:AMN) with a Outperform and raises the price target from $38 to $40.
A big investment expert still thinks AMN Healthcare is a good company and believes its stock could be worth a bit more money. When smart experts feel confident about a company, it often means they see good things ahead for it.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.